News of Note—Teva strikes labor agreement at Israeli plant

Woman typing on computer
(Max Pixel/CC0)

> Aurobindo this week reported that it has completed its €74 acquisition of generic and OTC drugs from Apotex in five European countries. The Hindu article

> Teva has completed a union agreement covering the 1,200 employees at its Kfar Saba plant in Israel that runs through 2019 and grants them a 2.2% raise. Globes artlcle

> Immunomedics, which received a CRL in January tied to its manufacturing plant in New Jersey, reported that it expects to sit down with the FDA after receiving an establishment inspection report for the facility. Filing

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

> WuXi Biologics and Amicus Therapeutics have struck an exclusive commercial manufacturing partnership for Amicus' Pompe biologic ATB200. Release

Suggested Articles

Having only just completed an expansion in Illinois, PCI Pharma Services will now expand its solid dose facility in Wales in the U.K.

The FDA has come down on a small U.S. drugmaker for taking a skin medication to market even though there were out-of-spec test results at release.

Sanofi, which has moved purposefully into high technologies to get more from its manufacturing, will lean even more on that strategy to save costs.